[thistle]

Guideline topic: Pharmacological management of asthma
Evidence table 4.3c: Theophyllines in exercise-induced asthma

Author

Year

Study type

Quality rating

Population

Outomes measured

Effect size

Confidence intervals / p values

Comments

Magnussen

1988

Randomised, double-blind, placebo-controlled, cross-over.

IV aminophylline 200-351mg vs placebo.

++

11 adults with asthma, aged 16-33 years

Exercise-induced bronchoconstriction

Protection index:

(for the different preparations of aminophylline)

TE 200: 0.61

TE 351: 0.82

TPD: 0.65

 

 

p< 0.01

p< 0.01

p< 0.01

A bolus of IV aminophyline significantly attenuated against EIA. Caution needed to extrapolate to oral dosing.

Phillips

1981

Randomised, double-blind, placebo controlled, cross-over.

1 week treatment with oral aminophyline or placebo

++

9 adults with asthma, aged 18-35 years

Exercise-induced bronchoconstriction

4h % fall in PEF

8h % fall in PEF

Placebo vs aminophylline:

30% vs 13%

29% vs 10%

 

p< 0.01

p< 0.05

Oral aminophylline for 1 week significantly attenuated EIA compared to placebo.

1. Magnussen H, Reuss G, Jorres R. Methylxanthines inhibit exercise-induced bronchoconstriction at low serum theophylline concentration and in a dose-dependent fashion. J Allergy Clin Immunol 1988;81(3):531-7.
2. Phillips MJ, Ollier S, Trembath PW, Boobis SW, Davies RJ. The effect of sustained-release aminophylline on exercise-induced asthma. Br J Dis Chest 1981;75(2):181-9.

Scottish Intercollegiate Guidelines Network
British guideline on the management of asthma <Home